BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nanda K, Moss AC. Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine. Clin Pharmacol. 2012;4:41-50. [PMID: 22888278 DOI: 10.2147/CPAA.S26556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 42.3] [Reference Citation Analysis]
2 Jhundoo HD, Siefen T, Liang A, Schmidt C, Lokhnauth J, Béduneau A, Pellequer Y, Larsen CC, Lamprecht A. Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis. Pharmaceutics 2020;12:E1038. [PMID: 33138176 DOI: 10.3390/pharmaceutics12111038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yang C, Merlin D. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. Int J Nanomedicine 2019;14:8875-89. [PMID: 32009785 DOI: 10.2147/IJN.S210315] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
4 Abraham A, Karakurum A. Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis. BMJ Case Rep. 2013;2013. [PMID: 23964037 DOI: 10.1136/bcr-2013-009834] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
5 Xiao HT, Peng J, Hu DD, Lin CY, Du B, Tsang SW, Lin ZS, Zhang XJ, Lueng FP, Han QB, Bian ZX. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice. Chin Med 2015;10:29. [PMID: 26464580 DOI: 10.1186/s13020-015-0061-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
6 Gupta M, Mishra V, Gulati M, Kapoor B, Kaur A, Gupta R, Tambuwala MM. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology 2022. [PMID: 35212849 DOI: 10.1007/s10787-022-00931-1] [Reference Citation Analysis]
7 Chen F, Yan CK. Recent progress in drug therapy of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2016; 24(12): 1840-1845 [DOI: 10.11569/wcjd.v24.i12.1840] [Cited by in F6Publishing: 2] [Reference Citation Analysis]